Cocrystal Pharma stock surges on FDA Fast Track designation Cocrystal Pharma stock surges on FDA Fast Track designation…
COCP: CDI-988 Data to be Presented at ICAR 2026 By David Bautz, PhDNASDAQ:COCPREAD THE FULL COCP RESEARCH REPORTBusiness UpdateCDI-988 to be Featured at ICAR2026On February 19, 2026, Cocrystal Pharma,…
Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial…